Population Impact of Heart Failure and the Most Common Forms of Cancer: A Study of 1 162 309 Hospital Cases in Sweden (1988 to 2004)

Background—The contemporary impact of heart failure (HF) versus the most common forms of cancer as reflected by related first-ever hospitalizations and subsequent case-fatality rates is unknown. Methods and Results—Using a national registry in Sweden, we compared the rate of first-ever hospitalization and associated short- and long-term survival for HF, acute myocardial infarction (AMI), and the most common forms of cancer on an age and sex-specific basis during 1988 to 2004 in 949 733 Swedish patients (1 162 309 hospital admissions in total). Annual incidence of first-ever hospitalization for HF, AMI, and cancer in Sweden were 484, 424, and 373 (lung, colorectal, prostate, and bladder cancer combined) per 100 000 men and 470, 280, and 350 (lung, colorectal, bladder, breast, and ovarian cancer combined) per 100 000 women age >20 years. The ratio of individual cases of HF to cancer was 1.37:1 (465 998 versus 340 738). Despite improvements in 30-day and 5-year survival (adjusted 7% and 6% increase per calendar year for men and women, respectively), HF was associated with unadjusted case-fatality rate of 59% within 5 years and 196 400 deaths versus 58% and 131 000 deaths in patients with cancer. During 10-year follow-up, HF was associated with 66 318 versus 55 364 premature life-years lost than all common forms of cancer in men. In women, the equivalent figures were 59 535 versus 64 533 premature life-years lost. Conclusions—These data confirm that, like most common forms of cancer combined, HF exerts a major health burden in respect to age-adjusted rates of first hospitalization, poor overall survival, and premature life-years lost.

[1]  V. Roger,et al.  Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.

[2]  S Capewell,et al.  Heart failure and the aging population: an increasing burden in the 21st century? , 2003, Heart.

[3]  A. Odén,et al.  Reducing uncertainty in health-care resource allocation , 2007, British Journal of Cancer.

[4]  D. Vanuzzo,et al.  Does surveillance impact on cardiovascular prevention? , 2009, European heart journal.

[5]  K. Swedberg,et al.  Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. , 2003, European Heart Journal.

[6]  F. Neumann,et al.  New definition of myocardial infarction: impact on long-term mortality. , 2008, The American journal of medicine.

[7]  R Westerling,et al.  Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. , 2000, International journal of epidemiology.

[8]  E. Ingelsson,et al.  The validity of a diagnosis of heart failure in a hospital discharge register , 2005, European journal of heart failure.

[9]  Daniel Levy,et al.  Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.

[10]  J. McMurray,et al.  Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.

[11]  Colin Simpson,et al.  Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.

[12]  Simon Stewart,et al.  Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.

[13]  B. Yawn,et al.  Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.

[14]  P. Wingo,et al.  How does breast cancer mortality compare with that of other cancers and selected cardiovascular diseases at different ages in U.S. women? , 2000, Journal of women's health & gender-based medicine.

[15]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[16]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[17]  J. Pater Quality of life and pharmacoeconomics in clinical trials , 1996 .

[18]  Adelaide M. Arruda-Olson,et al.  Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. , 2008, American heart journal.

[19]  J. Pell,et al.  Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study , 2001, The Lancet.

[20]  L. Pilotto [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.

[21]  B. Fagerberg,et al.  Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. , 1998, European heart journal.

[22]  S Capewell,et al.  More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.

[23]  J. McMurray,et al.  Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.

[24]  D. Grobbee,et al.  Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? , 2002, Heart.

[25]  B. G. Blijenberg,et al.  Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.

[26]  Fach,et al.  Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.

[27]  D R Jacobs,et al.  Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997: The Minnesota Heart Survey , 2001, Circulation.

[28]  J. Yee,et al.  Accuracy of ct colonography for detection of large adenomas and cancers , 2009 .

[29]  B. Gersh Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002 , 2010 .

[30]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[31]  A. Jemal,et al.  Cancer mortality in the United States by education level and race. , 2007, Journal of the National Cancer Institute.

[32]  M. Hashemzadeh,et al.  Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and comorbidities. , 2009, The American journal of cardiology.